{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:32:05Z","timestamp":1788244325744,"version":"build-2803163510"},"reference-count":201,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012371","name":"Faculty of Science and Engineering, University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.critrevonc.2023.103989","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T17:48:31Z","timestamp":1681408111000},"page":"103989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Thrombosis and cachexia in cancer: Two partners in crime?"],"prefix":"10.1016","volume":"186","author":[{"given":"Joana","family":"Liz-Pimenta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Vieira","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana M.O.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina Brand\u00e3o","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok A.","family":"Khorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-8373","authenticated-orcid":false,"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2023.103989_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000356760","article-title":"Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options-a mini-review","volume":"60","author":"Ali","year":"2014","journal-title":"Gerontology"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib3","first-page":"61","article-title":"Causes of death in cancer patients","volume":"6","author":"Ambrus","year":"1975","journal-title":"J. Med."},{"key":"10.1016\/j.critrevonc.2023.103989_bib4","first-page":"165","volume":"5","author":"Amer","year":"2013","journal-title":"Thromb.: Clin. Present. Surviv., Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","article-title":"ESPEN expert group recommendations for action against cancer-related malnutrition","volume":"36","author":"Arends","year":"2017","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO clinical practice guidelines\u2606","volume":"6","author":"Arends","year":"2021","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1096\/fasebj.11.10.9271359","article-title":"Journey from cachexia to obesity by TNF","volume":"11","author":"Argil\u00e9s","year":"1997","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10654-021-00813-w","article-title":"Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death","volume":"37","author":"Arnesen","year":"2022","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2023.103989_bib9","article-title":"Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial","volume":"378","author":"Auer","year":"2022","journal-title":"bmj"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cohen, Cancer-associated venous thromboembolism: Burden, mechanisms, and management","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"24","key":"10.1016\/j.critrevonc.2023.103989_bib11","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Marosi et al., Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2023.103989_bib12","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103989_bib13","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/jth.13842","article-title":"Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score","volume":"15","author":"Bertoletti","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2023.103989_bib14","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/10760296990050S103","article-title":"Clinical aspects of heparin-induced thrombocytopenia and thrombosis and other side effects of heparin therapy","volume":"5","author":"Bick","year":"1999","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"S1","key":"10.1016\/j.critrevonc.2023.103989_bib15","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2020.34.s1.09940","article-title":"Biological sex mediates cancer cachexia associated muscle weakness","volume":"34","author":"Blackburn","year":"2020","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib16","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1538-7836.2004.00928.x","article-title":"The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma","volume":"2","author":"Blom","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib17","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/nu13061980","article-title":"The spectrum of malnutrition\/cachexia\/sarcopenia in oncology according to different cancer types and settings: a narrative review","volume":"13","author":"Bossi","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-019-0510-x","article-title":"The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues","volume":"121","author":"Campello","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/rco2.30","article-title":"Mediators and clinical treatment for cancer cachexia: a systematic review","volume":"4","author":"Cao","year":"2021","journal-title":"JCSM Rapid Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-149-5-200809020-00007","article-title":"Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?","volume":"149","author":"Carrier","year":"2008","journal-title":"Ann. Intern Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin. Nutr."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1634\/theoncologist.2016-0246","article-title":"Preventing venous thromboembolism in ambulatory cancer patients: the ONKOTEV study","volume":"22","author":"Cella","year":"2017","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib23","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1378\/chest.124.3_suppl.11S","article-title":"Thrombin interactions","volume":"124","author":"Cera","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2023.103989_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2020-137525","article-title":"Abnormal metaphase cytogenetics adds to currently known risk-factors for venous thromboembolism in multiple myeloma: derivation of the PRISM score","volume":"136","author":"Chakraborty","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103989_bib26","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1210\/en.2005-0732","article-title":"In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring","volume":"146","author":"Chen","year":"2005","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib27","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1002\/jcb.28260","article-title":"PAR2 promotes M1 macrophage polarization and inflammation via FOXO1 pathway","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103989_bib28","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/jth.15519","article-title":"Overall survival with warfarin vs. low\u2010molecular\u2010weight heparin in cancer\u2010associated thrombosis","volume":"19","author":"Chiasakul","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.10.003","article-title":"The prothrombotic state in cancer: pathogenic mechanisms","volume":"50","author":"De Cicco","year":"2004","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1160\/TH15-08-0686","article-title":"Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study","volume":"117","author":"Cohen","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib31","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/jcsm.12449","article-title":"Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa, Journal of Cachexia","volume":"10","author":"Costa","year":"2019","journal-title":"Sarcopenia Muscle"},{"key":"10.1016\/j.critrevonc.2023.103989_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0036-1592333","article-title":"Environmental and genetic risk factors associated with venous thromboembolism","author":"Crous-Bou","year":"2016","journal-title":"Semin. Thromb. Hemost., Thieme Med. Publ."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/cncr.20347","article-title":"The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review","volume":"101","author":"Deitcher","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/011542650602100168","article-title":"The origins of cachexia in acute and chronic inflammatory diseases","volume":"21","author":"Delano","year":"2006","journal-title":"Nutr. Clin. Pract."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib35","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/jth.13791","article-title":"Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH","volume":"15","author":"Delluc","year":"2017","journal-title":"J. Thromb. Haemost.: JTH"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/apm.2018.08.07","article-title":"Measuring cachexia\u2014diagnostic criteria","volume":"8","author":"Dev","year":"2019","journal-title":"Ann. Palliat. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103989_bib38","first-page":"2191","article-title":"Chronic inflammation in obesity and cancer cachexia, journal of clinical medicine","volume":"11","author":"Divella","year":"2022"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1634\/theoncologist.2016-0214","article-title":"Cancer and venous thromboembolic disease: a review","volume":"22","author":"Donnellan","year":"2017","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib41","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/2326-6066.CIR-20-0372","article-title":"Understanding and overcoming the inflammatory toxicities of immunotherapy","volume":"8","author":"Dougan","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.46497\/ArchRheumatol.2020.7632","article-title":"Association between familial mediterranean fever and cachexia in females","volume":"35","author":"Durmaz","year":"2020","journal-title":"Arch. Rheumatol."},{"key":"10.1016\/j.critrevonc.2023.103989_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.peptides.2015.06.011","article-title":"Hypothalamic inflammation and food intake regulation during chronic illness","volume":"77","author":"Dwarkasing","year":"2016","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib44","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1378\/chest.124.3_suppl.26S","article-title":"The protein C pathway","volume":"124","author":"Esmon","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2023.103989_bib45","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/S0049-3848(14)50028-X","article-title":"Cancer-associated unsuspected pulmonary embolism","volume":"133","author":"van Es","year":"2014","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.7326\/M17-0868","article-title":"Screening for occult cancer in patients with unprovoked venous thromboembolism: a systematic review and meta-analysis of individual patient data","volume":"167","author":"Es","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103989_bib47","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3324\/haematol.2017.169060","article-title":"Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study","volume":"102","author":"Es","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jcsm.12059","article-title":"Pathophysiology of anorexia in the cancer cachexia syndrome","volume":"6","author":"Ezeoke","year":"2015","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"key":"10.1016\/j.critrevonc.2023.103989_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","article-title":"Mechanisms and risk factors of thrombosis in cancer","volume":"118","author":"Falanga","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02981929","article-title":"Pathogenesis of thrombosis in patients with malignancy","volume":"73","author":"Falanga","year":"2001","journal-title":"Int. J. Hematol."},{"issue":"29","key":"10.1016\/j.critrevonc.2023.103989_bib51","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1200\/JCO.2009.22.8197","article-title":"Venous thromboembolism in the hematologic malignancies","volume":"27","author":"Falanga","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib53","first-page":"90","article-title":"Understanding the mechanisms and treatment options in cancer cachexia, Nature reviews","volume":"10","author":"Fearon","year":"2013","journal-title":"Clin. Oncol."},{"issue":"151","key":"10.1016\/j.critrevonc.2023.103989_bib54","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0119-2018","article-title":"Alves et al., Cancer-associated thrombosis: the when, how and why","volume":"28","author":"Fernandes","year":"2019","journal-title":"Eur. Respir. Rev."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103989_bib56","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ. Res."},{"issue":"08","key":"10.1016\/j.critrevonc.2023.103989_bib57","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1160\/TH05-04-0266","article-title":"The relationship between inflammation and venous thrombosis","volume":"94","author":"Fox","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"04","key":"10.1016\/j.critrevonc.2023.103989_bib58","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0041-1732295","article-title":"Plasma levels of leptin and risk of future incident venous thromboembolism","volume":"122","author":"Frischmuth","year":"2022","journal-title":"Thromb. Haemost."},{"issue":"2013","key":"10.1016\/j.critrevonc.2023.103989_bib59","first-page":"Cd004310","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","volume":"3","author":"Garcia","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1073\/pnas.61.1.46","article-title":"Antimetastatic effects associated with platelet reduction","volume":"61","author":"Gasic","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib61","first-page":"306","volume":"2014","author":"Geerts, Central venous catheter\u2013related thrombosis","year":"2014","journal-title":"Hematol. 2014, Am. Soc. Hematol. Educ. Program Book"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib62","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS-cancer-associated thrombosis study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2023.103989_bib63","first-page":"204","article-title":"Clinical studies with anticoagulants to improve survival in cancer patients","author":"Gerotziafas","year":"2008","journal-title":"Pathophysiol. Haemost. Thromb. 36(3-4)"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2023.103989_bib64","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.thromres.2018.02.004","article-title":"Updated clinical models for VTE prediction in hospitalized medical patients","volume":"164","author":"Gerotziafas","year":"2018","journal-title":"Thromb. Res"},{"issue":"9_suppl","key":"10.1016\/j.critrevonc.2023.103989_bib65","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1177\/1076029618811109","article-title":"Vitamin K-dependent coagulation factors that may be responsible for both bleeding and thrombosis (FII, FVII, and FIX)","volume":"24","author":"Girolami","year":"2018","journal-title":"Clin. Appl. Thromb. \/Hemost."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rpor.2015.03.001","article-title":"Strojan, Malnutrition and cachexia in patients with head and neck cancer treated with (chemo) radiotherapy","volume":"20","author":"Gorenc","year":"2015","journal-title":"Rep. Pract. Oncol. Radiother."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103989_bib67","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3324\/haematol.2016.147405","article-title":"Br\u00e6kkan et al., Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism","volume":"101","author":"Gran","year":"2016","journal-title":"haematologica"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103989_bib68","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3324\/haematol.2018.192419","article-title":"Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer","volume":"103","author":"Grilz","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib69","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib70","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014","volume":"5","author":"von Haehling","year":"2014","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"key":"10.1016\/j.critrevonc.2023.103989_bib71","doi-asserted-by":"crossref","unstructured":"Hariyanto, Kurniawan, Cachexia in Cancer Patients: Systematic Literature Review, Asian Journal of Oncology (2020).","DOI":"10.1055\/s-0040-1713701"},{"key":"10.1016\/j.critrevonc.2023.103989_bib72","first-page":"309","article-title":"Measurement of blood coagulation factor synthesis in cultures of human hepatocytes, Protocols in In Vitro Hepatocyte","author":"Heinz","year":"2015","journal-title":"Res., Springe"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib73","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch. Intern Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","article-title":"The epidemiology of venous thromboembolism","volume":"41","author":"Heit","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib75","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103989_bib76","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-\u03baB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"He","year":"2013","journal-title":"J. Clin. Invest"},{"issue":"13","key":"10.1016\/j.critrevonc.2023.103989_bib77","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib78","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4103\/apjon.apjon_12_18","article-title":"Psychosocial support in cancer cachexia syndrome: the evidence for supported self-management of eating problems during radiotherapy or chemotherapy treatment","volume":"5","author":"Hopkinson","year":"2018","journal-title":"Asia Pac. J. Oncol. Nurs."},{"issue":"18","key":"10.1016\/j.critrevonc.2023.103989_bib79","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","article-title":"Ribociclib as first-line therapy for hr-positive, advanced breast cancer","volume":"375","author":"Hortobagyi","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib80","doi-asserted-by":"crossref","first-page":"162","DOI":"10.15386\/mpr-1372","article-title":"Association between obesity and venous thromboembolism","volume":"93","author":"Hotoleanu","year":"2020","journal-title":"Med. Pharm. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib81","doi-asserted-by":"crossref","first-page":"0137","DOI":"10.1007\/s101200200024","article-title":"Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factor","volume":"5","author":"Ikeda","year":"2002","journal-title":"Gastric Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103989_bib82","first-page":"640","article-title":"Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia\/weight loss trial","volume":"12","author":"Jatoi","year":"2004","journal-title":"Support. Care Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib83","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jcsm.12138","article-title":"New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss","volume":"8","author":"Johns","year":"2017","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"key":"10.1016\/j.critrevonc.2023.103989_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103782","article-title":"Venous thromboembolism in cancer and cancer immunotherapy","author":"Kacimi","year":"2022","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103989_bib85","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.3390\/cancers13122884","article-title":"The impact of thromboprophylaxis on the survival of patients with advanced pancreatic cancer. The pancreatic cancer and tinzaparin (PaCT) study","volume":"13","author":"Karamouzis","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103989_bib86","first-page":"2720","article-title":"Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis, Blood","volume":"98","author":"Kaser","year":"2001","journal-title":"J. Am. Soc. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib87","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib88","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Lyman, Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib89","first-page":"4902","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib90","first-page":"1","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103989_bib91","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/j.1538-7836.2003.00501.x","article-title":"Malignancy, thrombosis and Trousseau: the case for an eponym","volume":"1","author":"Khorana","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib92","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cncr.27772","article-title":"Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States","volume":"119","author":"Khorana","year":"2013","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib93","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-06-2351","article-title":"Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer","volume":"13","author":"Khorana","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib94","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1182\/bloodadvances.2021005710","article-title":"Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI","volume":"6","author":"Khorana","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2023.103989_bib95","first-page":"301","article-title":"Difference of colorectal cancer, sex\/gender-specific medicine in the gastrointestinal","author":"Kim","year":"2022","journal-title":"Diseases"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib96","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jcsm.12421","article-title":"Kidney cachexia or protein\u2010energy wasting in chronic kidney disease: facts and numbers, Journal of Cachexia","volume":"10","author":"Koppe","year":"2019","journal-title":"Sarcopenia Muscle"},{"key":"10.1016\/j.critrevonc.2023.103989_bib97","first-page":"400","article-title":"ACT\u2010ONE\u2010ACTION at last on cancer cachexia by adapting a novel action beta\u2010blocker","author":"Lainscak","year":"2016","journal-title":"Wiley Online Libr."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103989_bib98","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s12094-017-1682-6","article-title":"Supportive care in pancreatic ductal adenocarcinoma","volume":"19","author":"Laquente","year":"2017","journal-title":"Clin. Transl. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib99","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1200\/JOP.2017.025239","article-title":"Impact of socioeconomic status on pretreatment weight loss and survival in non-small-cell lung cancer","volume":"14","author":"Lau","year":"2018","journal-title":"J. Oncol. Pr."},{"issue":"611","key":"10.1016\/j.critrevonc.2023.103989_bib100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1259\/0007-1285-51-611-895","article-title":"Vascular permeability in the ears of rats after x-irradiation","volume":"51","author":"Law","year":"1978","journal-title":"Br. J. Radiol."},{"issue":"23 Suppl 1","key":"10.1016\/j.critrevonc.2023.103989_bib101","first-page":"I17","article-title":"Venous thromboembolism and cancer: risks and outcomes","volume":"107","author":"Lee","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.critrevonc.2023.103989_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.669288","article-title":"Ng, Epidemiology of cancer-associated thrombosis in Asia: a systematic review","volume":"8","author":"Lee","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2023.103989_bib103","article-title":"An overview of thrombotic complications of old and new anticancer drugs","volume":"191","author":"Levi","year":"2020","journal-title":"Thromb. Res"},{"issue":"22","key":"10.1016\/j.critrevonc.2023.103989_bib104","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/bloodadvances.2018024828","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism","volume":"2","author":"Lim","year":"2018","journal-title":"Blood Adv."},{"issue":"24","key":"10.1016\/j.critrevonc.2023.103989_bib105","first-page":"7436","article-title":"Association between Platelet Count with 1-year Survival in Patients with Cancer Cachexia, Journal of Cancer","volume":"12","author":"Liu","year":"2021"},{"issue":"15_suppl","key":"10.1016\/j.critrevonc.2023.103989_bib106","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.e20644","article-title":"The incidence and impact of weight loss with cachexia in gastric cancer patients","volume":"33","author":"Li","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103989_bib107","doi-asserted-by":"crossref","first-page":"840","DOI":"10.6004\/jnccn.2018.7273","article-title":"Derivation and validation of a risk assessment model for immunomodulatory drug\u2013associated thrombosis among patients with multiple myeloma","volume":"17","author":"Li","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib108","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jval.2017.09.015","article-title":"What impact does venous thromboembolism and bleeding have on cancer patients\u2019 quality of life?","volume":"21","author":"Lloyd","year":"2018","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib109","first-page":"225","article-title":"The lethal phenotype of cancer: the molecular basis of death due to malignancy","volume":"57","author":"Loberg","year":"2007","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib110","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1158\/1535-7163.MCT-18-1151","article-title":"Targeting the IGF1R\/PI3K\/AKT pathway sensitizes Ewing sarcoma to BET bromodomain inhibitors","volume":"18","author":"Loganathan","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2023.103989_bib111","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0049-3848(20)30402-3","article-title":"Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis","volume":"191","author":"Lyman","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2023.103989_bib112","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trsl.2020.06.011","article-title":"Hormones and thrombosis: risk across the reproductive years and beyond","volume":"225","author":"Machin","year":"2020","journal-title":"Transl. Res."},{"issue":"S2","key":"10.1016\/j.critrevonc.2023.103989_bib113","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/HS9.0000000000000073","article-title":"Pathogenesis of cancer-associated thrombosis","volume":"2","author":"Mackman","year":"2018","journal-title":"Hemasphere"},{"key":"10.1016\/j.critrevonc.2023.103989_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00298","article-title":"Management of cancer cachexia: attempting to develop new pharmacological agents for new effective therapeutic options","volume":"10","author":"Marceca","year":"2020","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103989_bib115","first-page":"764","article-title":"Megestrol acetate therapy in geriatric patients: case reviews and associated deep vein thrombosis","volume":"18","author":"Marshall","year":"2003","journal-title":"Consult Pharm."},{"issue":"171\u2013186","key":"10.1016\/j.critrevonc.2023.103989_bib116","article-title":"SEOM clinical guideline of venous thromboembolism (VTE) and cancer","author":"Martin","year":"2019","journal-title":"Clin. Transl. Oncol. 22(2) (2020)"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib117","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0884533617722986","article-title":"Cancer cachexia: cause, diagnosis, and treatment","volume":"32","author":"Mattox","year":"2017","journal-title":"Nutr. Clin. Pr."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-019-1073-3","article-title":"It\u2019s more than low BMI: prevalence of cachexia and associated mortality in COPD","volume":"20","author":"McDonald","year":"2019","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib119","article-title":"How I treat cancer-associated thrombosis","volume":"5","author":"Moik","year":"2020","journal-title":"ESMO Open"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103989_bib120","first-page":"1316","article-title":"Occult cancer in patients with venous thromboembolism: which patients, which cancers","volume":"78","author":"Monreal","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2023.103989_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2018.07.010","article-title":"Platinum-induced muscle wasting in cancer chemotherapy: mechanisms and potential targets for therapeutic intervention","volume":"208","author":"Moreira-Pais","year":"2018","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib122","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"104","author":"Mulder","year":"2019","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.critrevonc.2023.103989_bib123","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2023.103989_bib124","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fimmu.2019.00085","article-title":"Cell type-specific roles of NF-\u03baB linking inflammation and thrombosis","volume":"10","author":"Mussbacher","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103989_bib125","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/j.1538-7836.2007.02578.x","article-title":"Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?","volume":"5","author":"Napoleone","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib126","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/jcsm.12235","article-title":"Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia","volume":"9","author":"Narasimhan","year":"2017","journal-title":"J. Cachex-.-., Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030566","article-title":"Potential mechanisms of cancer-related hypercoagulability","volume":"12","author":"Nasser","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/039463200802100125","article-title":"Effects of the hormones of the thyroid axis on the vitamin K-dependent plasma factors of blood coagulation (II, VII, IX, and X)","volume":"21","author":"Negrev","year":"2008","journal-title":"Int J. Immunopathol. Pharm."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib129","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.21037\/apm-20-454","article-title":"Immunotherapy-related skeletal muscle weakness in cancer patients: a case series","volume":"10","author":"Ng","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.critrevonc.2023.103989_bib130","unstructured":"Odrow\u0105\u017c-Sypniewska, Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome, Advances in Medical Sciences (De Gruyter Open) 52 (2007)."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib131","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1160\/TH05-10-0694","article-title":"Sternby, Trousseau's syndrome - what is the evidence? A population-based autopsy study","volume":"95","author":"Ogren","year":"2006","journal-title":"Thromb. Haemost."},{"issue":"23","key":"10.1016\/j.critrevonc.2023.103989_bib132","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.7314\/APJCP.2014.15.23.10165","article-title":"Can megestrol acetate induce thrombosis in advanced oncology patients receiving chemotherapy?","volume":"15","author":"Ordu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib133","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/jcsm.12446","article-title":"The clinical relevance of adiposity when assessing muscle health in men treated with androgen deprivation for prostate cancer","volume":"10","author":"Owen","year":"2019","journal-title":"J. Cachex-.-., Sarcopenia Muscle"},{"key":"10.1016\/j.critrevonc.2023.103989_bib134","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib136","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.2016.3","article-title":"Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia","volume":"114","author":"Penafuerte","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2023.103989_bib137","doi-asserted-by":"crossref","unstructured":"Penna, Baccino, Costelli, Pathogenesis of cancer cachexia, Future Medicine2013.","DOI":"10.2217\/ebo.12.132"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib138","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1002\/cam4.2180","article-title":"Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities","volume":"8","author":"Permuth","year":"2019","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib139","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"Petruzzelli","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2023.103989_bib140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","article-title":"Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile","volume":"5","author":"Pietra","year":"2014","journal-title":"J. Cachex-.-., Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib141","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism","volume":"10","author":"Pin","year":"2019","journal-title":"J. Cachex-.-., Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103989_bib142","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/014107689709001103","article-title":"Pannuti, Miglioli, Home artificial nutrition in advanced cancer","volume":"90","author":"Pironi","year":"1997","journal-title":"J. R. Soc. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib143","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/ATVBAHA.118.311655","article-title":"Roles of coagulation proteases and PARs (protease-activated receptors) in mouse models of inflammatory diseases","volume":"39","author":"Posma","year":"2019","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib144","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/nu12061543","article-title":"Pancreatic cancer and cachexia\u2014metabolic mechanisms and novel insights","volume":"12","author":"Poulia","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jemermed.2018.05.026","article-title":"Pulmonary embolism among patients with acute exacerbation of chronic obstructive pulmonary disease: implications for emergency medicine","volume":"55","author":"Pourmand","year":"2018","journal-title":"J. Emerg. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib146","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1538-7836.2010.03797.x","article-title":"The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months","volume":"8","author":"Prandoni","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2023.103989_bib147","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ctrv.2018.10.002","article-title":"Cancer cachexia and myopenia\u2013Update on management strategies and the direction of future research for optimizing body composition in cancer\u2013A narrative review","volume":"70","author":"Pring","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib148","first-page":"4545","article-title":"Paraneoplastic thrombocytosis in breast cancer","volume":"33","author":"Rajkumar","year":"2013","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib149","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jth.13612","article-title":"Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin\u20106 dependent","volume":"15","author":"Reddel","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib150","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/jth.12678","article-title":"Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment","volume":"12","author":"Roach","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"21","key":"10.1016\/j.critrevonc.2023.103989_bib151","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO Guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"suppl 5","key":"10.1016\/j.critrevonc.2023.103989_bib152","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib153","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.medj.2021.02.002","article-title":"Increased incidence of venous thromboembolism with cancer immunotherapy","volume":"2","author":"Roopkumar","year":"2021","journal-title":"Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib154","first-page":"150","article-title":"Evidence-based mini-review: should all patients with idiopathic venous thromboembolic events be screened extensively for occult malignancy?","volume":"2010","author":"Rosovsky","year":"2010","journal-title":"Hematol. 2010, Am. Soc. Hematol. Educ. Program Book"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib155","first-page":"185","article-title":"Systemic and local inflammation in colorectal cancer","volume":"25","author":"Rumba","year":"2018","journal-title":"Acta Med. Litu."},{"key":"10.1016\/j.critrevonc.2023.103989_bib156","first-page":"2542","article-title":"TNF-\u03b1 (Tumor Necrosis Factor-\u03b1) A Paradox in","author":"Saha","year":"2018","journal-title":"Thromb., Am. Heart Assoc."},{"issue":"5714","key":"10.1016\/j.critrevonc.2023.103989_bib157","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/279636a0","article-title":"Human blood platelet adhesion to artery subendothelium is mediated by factor VIII\u2013von Willebrand factor bound to the subendothelium","volume":"279","author":"Sakariassen","year":"1979","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103989_bib158","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/ajh.25603","article-title":"Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score","volume":"94","author":"Sanfilippo","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib159","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/13816128113199990021","article-title":"Mechanisms linking leptin to arterial and venous thrombosis: potential pharmacological targets","volume":"20","author":"Schafer","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103989_bib160","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/jth.14474","article-title":"Endogenous sex hormones and risk of venous thromboembolism in young women","volume":"17","author":"Scheres","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib161","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-5273(02)00238-3","article-title":"Pulmonary cachexia","volume":"85","author":"Schols","year":"2002","journal-title":"Int J. Cardiol."},{"issue":"07","key":"10.1016\/j.critrevonc.2023.103989_bib162","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1160\/TH16-10-0823","article-title":"thromboembolism: past, present and future","volume":"117","author":"Schulman","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"35","key":"10.1016\/j.critrevonc.2023.103989_bib163","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1200\/JCO.2012.42.4358","article-title":"Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis","volume":"30","author":"Seng","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.critrevonc.2023.103989_bib164","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","article-title":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer","volume":"368","author":"Shaw","year":"2013","journal-title":"N. Engl. J. Med"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103989_bib165","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1523\/JNEUROSCI.13-08-03574.1993","article-title":"Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus","volume":"13","author":"Shintani","year":"1993","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib166","first-page":"291","article-title":"Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation","volume":"134","author":"Silva","year":"2019","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.critrevonc.2023.103989_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-20315-3_1","article-title":"Thrombosis and Hemostasis in Cancer. Scope of the Problem and Overview","volume":"179","author":"Soff","year":"2019","journal-title":"Cancer Treat. Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib168","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V64.2.567.567","article-title":"Irradiation induces release of von Willebrand protein from endothelial cells in culture","volume":"64","author":"Sporn","year":"1984","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103989_bib169","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcsm.12126","article-title":"Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non\u2010small cell lung cancer or colorectal cancer: a randomized, double\u2010blind, placebo\u2010controlled, international multicentre phase II study (the ACT\u2010ONE trial)","volume":"7","author":"Stewart Coats","year":"2016","journal-title":"J. Cachex-.-., Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib171","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOG.0000000000000603","article-title":"Quigley, Cancer cachexia: a multifactoral disease that needs a multimodal approach","volume":"36","author":"Stubbins","year":"2020","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib172","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-12-591","article-title":"\u201cIron-saturated\u201d bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice","volume":"12","author":"Sun","year":"2012","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib174","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jcsm.12251","article-title":"Circulating monocyte chemoattractant protein\u20101 (MCP\u20101) is associated with cachexia in treatment\u2010na\u00efve pancreatic cancer patients","volume":"9","author":"Talbert","year":"2018","journal-title":"J. Cachex-.-., Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/030089168907500223","article-title":"A study of thyroid function in cancer cachexia","volume":"75","author":"Tancini","year":"1989","journal-title":"Tumori"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib176","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/emmm.201200231","article-title":"P\u2010selectin genotype is associated with the development of cancer cachexia","volume":"4","author":"Tan","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103989_bib177","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12041-011-0027-4","article-title":"Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review","volume":"90","author":"Tan","year":"2011","journal-title":"J. Genet."},{"key":"10.1016\/j.critrevonc.2023.103989_bib178","article-title":"Medeiros, Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour","author":"Tavares","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2023.103989_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188778","article-title":"Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: A review of existing evidence","author":"Tavares","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2023.103989_bib180","first-page":"1","article-title":"Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients","author":"Tavares","year":"2020","journal-title":"Pharm. J."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib181","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1182\/bloodadvances.2020002998","article-title":"Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles","volume":"5","author":"Tawil","year":"2021","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib182","first-page":"267","article-title":"Thromboembolism in gastrointestinal cancers","volume":"2","author":"Tetzlaff","year":"2008","journal-title":"Gastrointest. Cancer Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103989_bib183","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2023.103989_bib184","doi-asserted-by":"crossref","DOI":"10.1152\/physiol.00019.2005","article-title":"Molecular pathways leading to cancer cachexia","author":"Tisdale","year":"2005","journal-title":"Physiology"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103989_bib185","first-page":"2353","article-title":"Purification and characterization of a tumor lipid-mobilizing factor","volume":"58","author":"Todorov","year":"1998","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103989_bib186","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00000421-199808000-00006","article-title":"Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia","volume":"21","author":"Vadell","year":"1998","journal-title":"Am. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib187","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2006-10-053736","article-title":"Trousseau's syndrome: multiple definitions and multiple mechanisms","volume":"110","author":"Varki","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103989_bib188","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","article-title":"A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score","volume":"7","author":"Verso","year":"2012","journal-title":"Intern Emerg. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib189","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1073\/pnas.81.2.471","article-title":"Willebrand protein binds to extracellular matrices independently of collagen","volume":"81","author":"Wagner","year":"1984","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib190","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1172\/JCI200318882","article-title":"Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas","volume":"112","author":"Wahrenbrock","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib191","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MCP.0b013e32832ee371","article-title":"Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms","volume":"15","author":"Wattanakit","year":"2009","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.critrevonc.2023.103989_bib192","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.oraloncology.2017.05.012","article-title":"Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer","volume":"71","author":"Wendrich","year":"2017","journal-title":"Oral. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103989_bib193","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/ejh.13590","article-title":"CDK 4\/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practice","volume":"106","author":"West","year":"2021","journal-title":"Eur. J. Haematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103989_bib194","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/jcm5120111","article-title":"Proteinase-activated receptor 2 is a novel regulator of TGF-\u03b2 signaling in pancreatic cancer","volume":"5","author":"Witte","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2023.103989_bib195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fphys.2020.00445","article-title":"Cancer cachexia induces preferential skeletal muscle myosin loss when combined with denervation","volume":"11","author":"Yamada","year":"2020","journal-title":"Front. Physiol."},{"issue":"25","key":"10.1016\/j.critrevonc.2023.103989_bib196","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.18632\/oncotarget.26764","article-title":"Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line","volume":"10","author":"Yanagihara","year":"2019","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103989_bib197","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070738","article-title":"A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis","volume":"8","author":"Yang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2023.103989_bib198","first-page":"778","article-title":"Risk factors and prediction models for venous thromboembolism in ambulatory patients with lung cancer","author":"Yan","year":"2021","journal-title":"Healthc., Multidiscip. Digit. Publ. Inst."},{"key":"10.1016\/j.critrevonc.2023.103989_bib199","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-021-00582-2","article-title":"Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor","author":"Yoo","year":"2021","journal-title":"Exp. Mol. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103989_bib200","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s11914-020-00628-w","article-title":"Sex differences in cancer cachexia","volume":"18","author":"Zhong","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103989_bib201","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11684-013-0263-5","article-title":"Leptin signaling and leptin resistance","volume":"7","author":"Zhou","year":"2013","journal-title":"Front. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282300077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282300077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:48:21Z","timestamp":1760903301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282300077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":201,"alternative-id":["S104084282300077X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103989","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis and cachexia in cancer: Two partners in crime?","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103989"}}